Isolation tool for viable c-kit expressing cells
CA 2468778 A1 · Owner: Janssen Pharmaceutica N.V. · Inventors: Wouters, Mira Maria Willy; Smans, Karine Alfonsine Astrid; Vanderwinden, Jean-Marie
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention provides a tool for the isolation of ck-it expressing cells. This tool consists of a c-kit plasmid targeting vector which is capable of integrating into the wild type c-kit allele and encodes a chimeric fluorescent protein comprising a nucleolar localisation signal such as TCOF-, 12, RLP313, RPS254 or Fxr2h5.. Said construct generates a condensed bright, fluorescent signal that can be localised in living tissue and after dissociation. The construct allows visualisation using confocal microscopy and allows automated cell sorting of the dissociated cells using amongst others flow cytometry.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed December 12, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended December 12, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by December 12, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.